FDA Seeks Comments on Revised Sepsis and Tuberculosis Transmission Guidelines for Human Cell and Tissue Products
May 03, 2025
May 03, 2025
WASHINGTON, May 3 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued notice of the withdrawal of two previously finalized guidance documents concerning the prevention of disease transmission through human cells, tissues, and cellular and tissue-based products (HCT/Ps), reissuing them instead as draft guidances for further public input.
The draft documents, titled "Recommendations to Reduce the Risk of Transmission of Disease Age . . .
The draft documents, titled "Recommendations to Reduce the Risk of Transmission of Disease Age . . .